Hazel Hunt - Net Worth and Insider Trading

Hazel Hunt Net Worth

The estimated net worth of Hazel Hunt is at least $4 Million dollars as of 2024-11-10. Hazel Hunt is the Chief Scientific Officer of Corcept Therapeutics Inc and owns about 73,146 shares of Corcept Therapeutics Inc (CORT) stock worth over $4 Million. Details can be seen in Hazel Hunt's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hazel Hunt has not made any transactions after 2023-08-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Hazel Hunt

To

Hazel Hunt Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hazel Hunt owns 1 companies in total, including Corcept Therapeutics Inc (CORT) .

Click here to see the complete history of Hazel Hunt’s form 4 insider trades.

Insider Ownership Summary of Hazel Hunt

Ticker Comapny Transaction Date Type of Owner
CORT Corcept Therapeutics Inc 2023-08-14 Chief Scientific Officer

Hazel Hunt Latest Holdings Summary

Hazel Hunt currently owns a total of 1 stock. Hazel Hunt owns 73,146 shares of Corcept Therapeutics Inc (CORT) as of August 14, 2023, with a value of $4 Million.

Latest Holdings of Hazel Hunt

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CORT Corcept Therapeutics Inc 2023-08-14 73,146 59.60 4,359,502

Holding Weightings of Hazel Hunt


Hazel Hunt Form 4 Trading Tracker

According to the SEC Form 4 filings, Hazel Hunt has made a total of 1 transactions in Corcept Therapeutics Inc (CORT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Corcept Therapeutics Inc is the sale of 20,455 shares on August 14, 2023, which brought Hazel Hunt around $631,855.

Insider Trading History of Hazel Hunt

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Hazel Hunt Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Hazel Hunt Ownership Network

Ownership Network List of Hazel Hunt

No Data

Ownership Network Relation of Hazel Hunt

Insider Network Chart

Hazel Hunt Owned Company Details

What does Corcept Therapeutics Inc do?

Who are the key executives at Corcept Therapeutics Inc?

Hazel Hunt is the Chief Scientific Officer of Corcept Therapeutics Inc. Other key executives at Corcept Therapeutics Inc include Chief Development Officer William Guyer , CHIEF FINANCIAL OFFICER Gary Charles Robb , and Chief Accounting Officer Joseph Douglas Lyon .

Corcept Therapeutics Inc (CORT) Insider Trades Summary

Over the past 18 months, Hazel Hunt made 1 insider transaction in Corcept Therapeutics Inc (CORT) with a net sale of 20,455. Other recent insider transactions involving Corcept Therapeutics Inc (CORT) include a net sale of 70,000 shares made by Joseph Douglas Lyon , a net sale of 28,750 shares made by Swisher Daniel N Jr , and a net sale of 225,000 shares made by Sean Maduck .

In summary, during the past 3 months, insiders sold 44,101 shares of Corcept Therapeutics Inc (CORT) in total and bought 0 shares, with a net sale of 44,101 shares. During the past 18 months, 517,899 shares of Corcept Therapeutics Inc (CORT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 517,899 shares.

Corcept Therapeutics Inc (CORT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Corcept Therapeutics Inc Insider Transactions

No Available Data

Hazel Hunt Mailing Address

Above is the net worth, insider trading, and ownership report for Hazel Hunt. You might contact Hazel Hunt via mailing address: C/o Corcept Therapeutics Incorporated, 149 Commonwealth Drive, Menlo Park Ca 94025.